Furthermore, the intracerebral administration of AEVs derived from ischemic astrocytes with anti-inflammatory properties, including CD63 and CD9 tetraspanins and miR-146a-5p, induced anti-inflammatory responses in the peri-infarct glial scars and facilitated stroke recovery. Here, CD9 is linked to stroke disorder.